[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Valentina |
| 2. | Perekonnanimi | Tefanova |
| 3. | Töökoht | Tervise Arengu Instituut ( TAI ) |
| 4. | Ametikoht | vanemteadur |
| 5. | Sünniaeg | 27.09.1949 (päev.kuu.aasta) |
| 6. | Haridus | Leningradi Meditsiiniline Pediaatria Instituut, 1975 |
| 7. | Teenistuskäik | Kliiniline sihtordinatuur laste onkohematoloogia alal, Meditsiiniteaduste Akadeemia Onkoloogiakeskus, Moskva, 1979-1981 Tallinna Epidemioloogia, Mikrobioloogia ja Hügieeni TU Instituut(TEMHTUI), viroloogia osakond, nooremteadur, 1982-1988 Profülaktilise Meditsiini Instituut (PMI, endine TEMHTUI) viroloogia os. vanemteadur, 1988-1997 TAI (endine Eksperimentaalse ja Kliinilise Meditsiini Instituut, EKMI) viroloogia os. vanemteadur, alates 09.1997 k.a. |
| 8. | Teaduskraad | Meditsiinikandidaat immunoloogias ja allergoloogias ja viroloogias |
| 9. | Teaduskraadi välja andnud asutus, aasta |
N.I.Pirogovi nim. Meditsiini Instituut, Moskva, 1987 |
| 10. | Tunnustused | ei |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
PMI-s ja TAI-s(s.h.EKMI-s) töötamise ajal 7 plaanilise teadustöö läbiviimisel vastutav täitja neljas ja teema juht ühes teadusteemas. Vastutav täitja neljas ETF grandis( reg.nr.381, 1993, 4218 ja 5961) Eesti Immunoloogide Seltsi liige, al. 1984-st Kliinilise Viroloogia Euroopa Seltsi liige, al.1994-st Eesti Laborimeditsiini Ühingu liige, al.2004-st PMI viroloogia osakonna stažööri N.Nikiforova diplomitöö teaduslik juhendaja, 1996 |
| 12. | Juhendamisel kaitstud väitekirjad |
|
| 13. | Teadustöö põhisuunad | Varem- Ägedaid respiratoorseid viirusnakkusi sageli põdevate eelkooliealiste laste immuunstaatuse iseärasused Al.1994.a-st:B- ja C-viirushepatiitide immunoepidemioloogilised omadused riskirühmades.Immuunsüsteemi erinevad aspektid viirushepatiitide korral Al. 1999.a-st:Molekulaar-epidemioloogilised uuringud A-,B- ja C-hepatiitide puhul Eestis |
| 14. | Jooksvad grandid | ETF grant nr.5961: Molekulaar-epidemioloogiline uuring Eestis isoleeritud B-hepatiidiviiruse genotüüpide leviku ja kliinilise tähtsuse väljaselgitamiseks, 2004-2007, vastutav täitja |
| 15. | Teaduspublikatsioonid |
Adojaan M, Kivisild T, Mannik A, Krispin T, Ustina V, Zilmer K, Liebert E, Jaroslavtsev N, Priimägi L, Tefanova V, Schmidt E, Krohn K, Villems R, Salminen M, Ustav M. Predominance of rare type of HIV-1 in Estonia. J Acquir Immune Defic Syndr. 2005, 39, 5:598-605 Priimägi L, Tefanova V, Tallo T. Emerging viral hepatitis B and C in Estonia. Emerging Biological Threat. NATO Science Series. Series 1. Life and Behavioural Sciences, Ed. by G Berencsi, AS Khan, J Haloužka. IOS Press Amsterdam, Berlin, Oxford, Tokyo, Washington, DC. Published in cooperation with NATO Public Diplomacy Division, 2005, v. 370, 20-25. Priimägi L, Tefanova, V, Tallo T, Schmidt E. The role of serum Th1 and Th2 cytokines in patients with chronic hepatitis B and C virus infection. Acta Medica Lituanica, 2005, 12, 3:28-31 Tallo T, Norder H, Tefanova V, Krispin T, Priimägi L, Mukomolov S, Mikhailov S, Magnius LO. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4. J Med Virol, 2004 Oct; 74(2):221-7. Tefanova V, Tallo T, Jaroslavtsev N, Kikosh G, Krupskaja L, Lisitsina S, Kutsar K, Priimägi L. B- ja C-viirushepatiidid - aktuaalne epidemioloogiline probleem Eestis viimasel aastakümnel. Eesti Arst, 2004, 83(8):559-562. Priimägi L, Tefanova V, Tallo T, Schmidt E, Solomonova O, Tuisk T. Th1 and Th2 cytokines in chronic viral hepatitis B and C infection. Voprosy Virusologii, 2003, 48(4):37-40. Tallo T, Norder H, Tefanova V, Ott K, Prükk T, Solomonova O, Schmidt J, Zilmer L, Priimägi L, Krispin T, Magnius L. Sequental changes in hepatitis A virus genotype distribution in Estonia during 1994 to 2001. J Med Virol 2003, 70(2):187-193. Tefanova V, Priimägi L, Tallo T, Jaroslavtsev N. Hepatitis B and C infection among intravenous drug users in prisons and visitors of anonymous consulting rooms in Estonia: prevalence and risk factors. Connections, 2003 Nov; 14:8-9. Priimägi L, Tefanova V, Tallo T, Schmidt E, Solomonova O, Tuisk T, Kikoš G, Krupskaja L, Lisitsyna S. Th1-cytokines in chronic hepatitis B and C. Voprosy Virusologii, 2002, 47(3):23-27. Tefanova V, Tallo T, Priimägi L, Kikoš G, Krupskaja L, Lisitsyna S, Noorlind J. Hepatitis A in Estonia (1990-1999). Zh Mikrobiol Epidemiol Immunobiol 2002, (2):22-26. 20 Tefanova V, Priimägi L, Tallo T. Functional and metabolic activity of peripheral blood neutrophiles in acute viral hepatitis B and C. Zh Mikrobiol Epidemiol Immunobiol 2001, 1:43-47. Tallo T, Lappalainen M, Tefanova V, Priimägi L. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in Northern Estonia. Acta virologica 2000, 44(3-4):175-178. Priimägi L, Kremerman I, Tallo T, Tefanova V, Luman M, Osadšaja G. The interferon system in patients maintained by hemodialysis, infected with hepatitis B and C. Voprosy Virusologii, 1999, 44(4):167-169. Priimägi L, Tefanova V, Tallo T, Osadšaja G. The function of the interferon system in inapparent and clinical hepatitis B and C infection. Voprosy Virusologii, 1999, 44, 2:85-88. TefanovaV,TalloT,PriimägiL,KikošG,KrupskajaL.EpidemiologicalaspectsofviralhepatitisinEstonia.ZhMikrobiolEpidemiolImmunobiol1999,2:39-42. |
viimati muudetud: 13.10.2005
| Curriculum Vitae (CV) | ||
| 1. | First Name | Valentina |
| 2. | Surname | Tefanova |
| 3. | Institution | National Institute for Health Development(NIHD) |
| 4. | Position | senior researcher |
| 5. | Date of birth | 27.09.1949 (day.month.year) |
| 6. | Education | Leningrad´s Pediatric Medical Institute,MD, 1975 |
| 7. | Research and professional experience |
Tallinn Research Institute of Epidemiology, Microbiology and Hygiene(TRI EMH) Virology Department, junior researcher, 1982-1988 Institute of Preventive Medicine (former TRI EMH), Virology Dept., senior researcher, 1988-1997 NIHD (former Estonian Institute of Experimental and Clinical Medicine), Virology Dept., senior researcher, 1997 till now |
| 8. | Academic degree | Ph.D., Immunology and Allergology and Virology |
| 9. | Dates and sites of earning the degrees |
N.I.Pirogov Medical Institute, Moscow, 1987 |
| 10. | Honours/awards | no |
| 11. | Research-administrative experience |
Working at the IPM and NIHD the executor in seven scientific themes and once as the principal investigator.Co-executor in four grants of Estonian Science Foundation The member of Estonian Society for Immunology, from 1984 The member of European Society for Clinical Virology, from 1994 The member of Estonian Society for Laboratory Medicine, from 2004 Chief of the Diploma N.Nikiforova, probationer, Virology Dept.,IPM,1996 |
| 12. | Supervised dissertations | |
| 13. | Current research program | Immunoepidemiology of viral hepatitis B and C in groups at increased risk for exposure Functional state of immune system at the various course of viral hepatitis Molecular-epidemiological investigations of hepatitis A,B and C viruses in Estonia |
| 14. | Current grant funding | ESF grant nr.5961: Genotypes of HBV strains isolated in Estonia, their prevalence and clinical relevance: molecular epidemiological study, 2004-2007 |
| 15. | List of most important publications |
Adojaan M, Kivisild T, Mannik A, Krispin T, Ustina V, Zilmer K, Liebert E, Jaroslavtsev N, Priimägi L, Tefanova V, Schmidt E, Krohn K, Villems R, Salminen M, Ustav M. Predominance of rare type of HIV-1 in Estonia. J Acquir Immune Defic Syndr. 2005, 39, 5:598-605 Priimägi L, Tefanova V, Tallo T. Emerging viral hepatitis B and C in Estonia. Emerging Biological Threat. NATO Science Series. Series 1. Life and Behavioural Sciences, Ed. by G Berencsi, AS Khan, J Haloužka. IOS Press Amsterdam, Berlin, Oxford, Tokyo, Washington, DC. Published in cooperation with NATO Public Diplomacy Division, 2005, v. 370, 20-25. Priimägi L, Tefanova, V, Tallo T, Schmidt E. The role of serum Th1 and Th2 cytokines in patients with chronic hepatitis B and C virus infection. Acta Medica Lituanica, 2005, 12, 3:28-31 Tallo T, Norder H, Tefanova V, Krispin T, Priimägi L, Mukomolov S, Mikhailov S, Magnius LO. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4. J Med Virol, 2004 Oct; 74(2):221-7. Tefanova V, Tallo T, Jaroslavtsev N, Kikosh G, Krupskaja L, Lisitsina S, Kutsar K, Priimägi L. B- ja C-viirushepatiidid - aktuaalne epidemioloogiline probleem Eestis viimasel aastakümnel. Eesti Arst, 2004, 83(8):559-562. Priimägi L, Tefanova V, Tallo T, Schmidt E, Solomonova O, Tuisk T. Th1 and Th2 cytokines in chronic viral hepatitis B and C infection. Voprosy Virusologii, 2003, 48(4):37-40. Tallo T, Norder H, Tefanova V, Ott K, Prükk T, Solomonova O, Schmidt J, Zilmer L, Priimägi L, Krispin T, Magnius L. Sequental changes in hepatitis A virus genotype distribution in Estonia during 1994 to 2001. J Med Virol 2003, 70(2):187-193. Tefanova V, Priimägi L, Tallo T, Jaroslavtsev N. Hepatitis B and C infection among intravenous drug users in prisons and visitors of anonymous consulting rooms in Estonia: prevalence and risk factors. Connections, 2003 Nov; 14:8-9. Priimägi L, Tefanova V, Tallo T, Schmidt E, Solomonova O, Tuisk T, Kikoš G, Krupskaja L, Lisitsyna S. Th1-cytokines in chronic hepatitis B and C. Voprosy Virusologii, 2002, 47(3):23-27. Tefanova V, Tallo T, Priimägi L, Kikoš G, Krupskaja L, Lisitsyna S, Noorlind J. Hepatitis A in Estonia (1990-1999). Zh Mikrobiol Epidemiol Immunobiol 2002, (2):22-26. 20 Tefanova V, Priimägi L, Tallo T. Functional and metabolic activity of peripheral blood neutrophiles in acute viral hepatitis B and C. Zh Mikrobiol Epidemiol Immunobiol 2001, 1:43-47. Tallo T, Lappalainen M, Tefanova V, Priimägi L. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in Northern Estonia. Acta virologica 2000, 44(3-4):175-178. Priimägi L, Kremerman I, Tallo T, Tefanova V, Luman M, Osadšaja G. The interferon system in patients maintained by hemodialysis, infected with hepatitis B and C. Voprosy Virusologii, 1999, 44(4):167-169. Priimägi L, Tefanova V, Tallo T, Osadšaja G. The function of the interferon system in inapparent and clinical hepatitis B and C infection. Voprosy Virusologii, 1999, 44, 2:85-88. TefanovaV,TalloT,PriimägiL,KikošG,KrupskajaL.EpidemiologicalaspectsofviralhepatitisinEstonia.ZhMikrobiolEpidemiolImmunobiol1999,2:39-42. |
last updated: 13.10.2005
[ sulge aken ]